N/A(healthy adults)
Conditions
Interventions
Single ingestion of the test food - single ingestion of the placebo food
Single ingestion of the placebo food - single ingestion of the test food
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Men and women aged 20 to 65 years at the time of obtaining consent. 2)BMI of 18.5 kg/m^2or more but less than 25.0 kg/m^2. 3)Those who have received sufficient explanation of the test, understand the contents, and can give written consent in person. 4) Those who have completed two doses of the new coronavirus vaccine.
Exclusion criteria
Exclusion criteria: 1)Those who have current medical treatments, or who are planning some kind of treatment the test period. 2)Those who constantly use medicines that may affect test results.(diuretic, antidiuretic, etc.).Those who take health foods and supplements (oral rehydration solution, saw palmettoetc.) daily, and those who may take or take them during the test period. 3)Those who are scheduled to take medication or receive vaccinations between one week before the first test date and the second test date. 4)Those who may onset seasonal allergies such as hay fever and take medicines during test period. 5)Those who may change their lifestyle (night shift, long trip, etc.) during test period. 6)Heavy drinkers of alcohol. 7)Those who have a history or current history of serious diseases of the heart, liver, kidneys, digestive organs, etc. 8)Individuals with probable seasonal allergy, such as pollinosis, during the test period. 9) Those who are pregnant, lactating, or intend to become pregnant during the study period. 10)Those with allergies to medicines or food. 11)Those who are currently participating in a clinical trial of another drug or health food, and plan to participate in another clinical trial within 4 weeks of the end of the trial, or after consenting to participate in the trial. 12)Patients who are judged to be inappropriate for participation in the study by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total body water | — |
Countries
Japan
Contacts
Public ContactMakoto Morinaga
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed